Mirisetron
Alternative Names: SEC 579; WAY 100579; WAY SEC 579Latest Information Update: 22 Nov 1999
At a glance
- Originator Wyeth
- Class Anxiolytics
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Cognition disorders; Sleep disorders
Most Recent Events
- 22 Nov 1999 Discontinued-I for Anxiety disorders in USA (Unknown route)
- 22 Nov 1999 Discontinued-I for Sleep disorders in USA (Unknown route)
- 22 Nov 1999 Discontinued-Preclinical for Cognition disorders in United Kingdom (Unknown route)